UCLA Cardiovascular Center
Los Angeles, California 90095
1 studies enrolling now · 4 studies all time
What they study most
Atrial Fibrillation, Cardiomyopathy, Urothelial Carcinoma
Studies at this site
- A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
- Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 — Running, not enrolling
- Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) — Completed
- Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy — Completed